Case Study Biodimed

Support for a Biotech Company entering the french market with an orphan drug.

Support for a Biotech Company entering the french market with an orphan drug.

Further Cases


Case Study FIECON

Driving a >£1M ICER for a severe and debilitating rare disease to acceptable levels for reimbursement in England and Wales.


Case Study SmartStep Nordics

Market Access Sweden for prescription and hospital drugs.


Case Study RPN

Regulatory Pharma Net

RPN has experience with a wide range of therapeutic areas and particularly with orphan and advanced-therapy medicinal products. RPN support includes early access and P&MA strategic assessments, advisory boards, stakeholder management and full support with national and regional P&R negotiations.

View Case

Case Study SmartStep Consulting

Be prepared.

SmartStep Healthcare Strategy & Market Access Consulting provides personalized and specialized consulting services to the pharmaceutical and medical device industries to provide fast and effective market access to their products in Germany.

View Case